Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-25 @ 2:44 AM
NCT ID:
NCT04453033
Eligibility Criteria:
Inclusion Criteria:
Diagnosis of Parkinson's disease as determined by the study PI, in keeping with the UK PD Society Brain Bank Criteria for the Diagnosis of PD
Responsiveness to dopaminergic medication, as judged by the rater, and have been using treatment for at least the past 1 year
Relatively good eyesight as attested to by participants (Corrective lenses of at least 20/60)
Stable levodopa and other anti-PD medications for at least 28 days prior to screening -
Exclusion Criteria:
Diagnosis of an atypical Parkinsonian syndrome
Significant OFF state or bothersome dyskinesias that in the judgment of the rater, would interfere with participation in the study.
An anticipated need for a change in dopamine replacement therapy, concomitant medications, OTC/supplements, or other alternative therapies during the participant's involvement in the investigation
History of previous light therapy use for PD
\-
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT04453033
Study Brief:
Protocol Section:
NCT04453033